Exact Mass: 573.268

Exact Mass Matches: 573.268

Found 51 metabolites which its exact mass value is equals to given mass value 573.268, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-[4-[2-[Benzyl-[3-(3,4-dimethoxyphenyl)propanoyl]amino]ethyl]phenyl]quinoline-3-carboxamide

C36H35N3O4 (573.2627)

His Phe Arg Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]butanedioic acid

C25H35N9O7 (573.2659)

Netilmicin sulfate

C21H43N5O11S (573.268)

Asp Phe His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C25H35N9O7 (573.2659)

Asp Phe Arg His

(3S)-3-amino-3-{[(1S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

Asp His Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C25H35N9O7 (573.2659)

Asp His Arg Phe

(3S)-3-amino-3-{[(1S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

Asp Arg Phe His

(3S)-3-amino-3-{[(1S)-4-carbamimidamido-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}butyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

Asp Arg His Phe

(3S)-3-amino-3-{[(1S)-4-carbamimidamido-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

Phe Asp His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C25H35N9O7 (573.2659)

Phe Asp Arg His

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

Phe Phe Phe Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C31H35N5O6 (573.2587)

Phe Phe Asn Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C31H35N5O6 (573.2587)

Phe His Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C25H35N9O7 (573.2659)

Phe His Arg Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]butanedioic acid

C25H35N9O7 (573.2659)

Phe Asn Phe Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C31H35N5O6 (573.2587)

Phe Arg Asp His

(3S)-3-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

Phe Arg His Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]butanedioic acid

C25H35N9O7 (573.2659)

His Asp Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C25H35N9O7 (573.2659)

His Asp Arg Phe

(3S)-3-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

His Phe Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C25H35N9O7 (573.2659)

His Arg Asp Phe

(3S)-3-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

His Arg Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]butanedioic acid

C25H35N9O7 (573.2659)

Asn Phe Phe Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C31H35N5O6 (573.2587)

Arg Asp Phe His

(3S)-3-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

Arg Asp His Phe

(3S)-3-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

Arg Phe Asp His

(3S)-3-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

Arg Phe His Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]butanedioic acid

C25H35N9O7 (573.2659)

Arg His Asp Phe

(3S)-3-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C25H35N9O7 (573.2659)

Arg His Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]butanedioic acid

C25H35N9O7 (573.2659)

DPTIE

Asp Pro Thr Ile Glu

C24H39N5O11 (573.2646)

CID 3247242

C33H36FN3O5 (573.2639)

2-[[2-[[(3,5-dimethylphenyl)-oxomethyl]-methylamino]-1-oxo-3-(4-phenylphenyl)propyl]amino]-3-(1H-indol-3-yl)propanoic acid

C36H35N3O4 (573.2627)

(1R)-2-(1,3-benzodioxol-5-ylmethyl)-N-(3,5-dimethyl-4-isoxazolyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide

C31H35N5O6 (573.2587)

alpha-L-Rhap-(1->3)-beta-D-Glcp-(1->4)-alpha-D-GlcpO[CH2]5NH2

C23H43NO15 (573.2633)

5-aminopentyl beta-D-glucopyranosyl-(1->3)-6-deoxy-alpha-L-talopyranosyl-(1->3)-beta-D-glucopyranoside

C23H43NO15 (573.2633)

5-aminopentyl beta-D-galactopyranosyl-(1->2)-alpha-D-galactopyranosyl-(1->3)-beta-L-rhamnopyranoside

C23H43NO15 (573.2633)

Netilmicin sulfate(2:5)

C21H43N5O11S (573.268)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors

Lnaps 3:0/N-18:4

C27H44NO10P (573.2703)

Lnaps 18:4/N-3:0

C27H44NO10P (573.2703)

2-amino-3-[hydroxy-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxypropanoic acid

C27H44NO10P (573.2703)

2-amino-3-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C27H44NO10P (573.2703)

PE 18:4/4:1;O2

C27H44NO10P (573.2703)

PE 22:5;O2

C27H44NO10P (573.2703)

LNAPS 21:4

C27H44NO10P (573.2703)

ST 25:3;O7;Tau

C27H43NO10S (573.2608)

ST 29:7;O4;Tau

C31H43NO7S (573.276)

IRL 2500

C36H35N3O4 (573.2627)

IRL 2500 is a potent Endothelin receptor antagonist. IRL 2500 shows IC50?values of 1.3 and 94 nM for ETB?and ETA?receptors, respectively. IRL 2500 inhibits ETB?receptor-mediated blood pressure increase and renal vascular resistance in rats?in vivo[1].